Kate Rosettie, MPH

Principal Health Economist, Economic Modeling
Genentech, Inc.

Poster(s):

• (246) Quantifying the productivity burden of lupus nephritis and the potential value of obinutuzumab treatment
  Wednesday, October 29, 2025